Science journalism · Not medical advice Regulatory window · PCAC review in 42 days

Content Disclaimer.

Wolverine writes science journalism, not medical advice. We cover peptide research, regulatory shifts, and the longevity ecosystem with the rigour of a beat reporter and the perspective of an opinionated editor. We are not a clinical service.

Nothing on wolverine.health constitutes medical advice, diagnosis, treatment, or prescribing of any substance. Consult a licensed clinician before making any decision about your health. Information presented reflects research and reporting as of the publication date and may be incomplete or out of date. Wolverine does not sell, prescribe, or recommend the substances discussed.

About this site.

Wolverine is an independent editorial publication covering peptide therapy, longevity, and the regulatory landscape surrounding both. The brand voice is Momentous-adjacent — premium, science-forward, dark, opinionated, anti-Juniper-soft. Our audience is performance-minded biohackers and longevity-focused adults aged 28–55 who are already evaluating peptide therapy and want a science-journalism source that takes the topic seriously without crossing into clinical recommendation.

We are not a clinical service. We do not sell peptides, do not prescribe, do not run a compounding pharmacy, and do not partner with prescribers in v1. Phase 8 (post-FDA reclassification window) adds a regulated clinical platform on app.wolverine.health as a separate surface with separate compliance posture.

Sourcing.

Wolverine's content factory ingests from regulatory primary sources (FDA, FTC, Federal Register, PubMed, ClinicalTrials.gov), editorial peers, and industry publications. Architectural enforcement of cite-don't-republish is in place at the schema level:

  • Every cited chunk is ≤50 words (fair-use boundary) — the schema ceiling lives in packages/shared/src/schema/provenance.ts.
  • Every article carries a provenance.json sidecar with URLs, accessed_at timestamps, content hashes, and license-basis declarations.
  • License types in use: public-domain, fair-use, licensed, rss-permitted.

See Editorial Standards for the full attribution policy.

AI assistance.

Per HIGH-5 mitigation (hidden AI authorship): Wolverine articles are AI-assisted and human-reviewed. Every article's aiDisclosure field (Zod-validated) declares:

  • aiAssisted: true — drafts originate from a multi-stage AI pipeline (Mastra orchestrator with planner / retriever / dialectic / drafter / fact-checker / guardrails / GEO-shaper stages).
  • humanReviewed: true — every article passes editor review before publish.
  • clinicalReviewerId: null (v1) — Phase 8 adds named clinical advisor as a value here.

Editorial methodology is described in detail at Editorial Methodology.

Corrections and updates.

Wolverine maintains a corrections policy:

  • Material errors trigger a correction notice at the top of the affected article and an entry in the global corrections log.
  • Substantial updates (new regulatory information, retracted source) trigger a revised lastReviewedAt date and a "What changed" footer block.
  • All historical versions are preserved in version control; the public-facing article shows the latest reviewed version.

See Editorial Standards: Corrections for the full policy.

Affiliate disclosure.

Wolverine does not operate affiliate links in v1. We do not earn commission from clicks to vendors, telehealth competitors, or grey-market peptide sources. Editorial integrity over revenue-by-association.

When affiliate relationships are added in a future phase, they will be disclosed in this section and at the top of any affected article, with the relationship made explicit.

Contact and DMCA.